Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “LRRK2”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 0 results

Not applicableLooking for participantsNCT06993142
What this trial is testing

Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage

Who this might be right for
Parkinson DiseaseProdromal StageNeurodegenerative Diseases+8 more
Radboud University Medical Center 600
Early research (Phase 1)Study completedNCT05009199
What this trial is testing

Occupancy of Adenosine A2A Receptors Using the PET Radiotracer [18F]MNI-444

Who this might be right for
Healthy Volunteer
Invicro 3
Not applicableStudy completedNCT04603326
What this trial is testing

FoxBioNet: ECV (Extracellular Vesicle) 004

Who this might be right for
Parkinson Disease
Michael J. Fox Foundation for Parkinson's Research 140
Not applicableLooking for participantsNCT03523104
What this trial is testing

Chinese PD-LRRK2 Registry

Who this might be right for
Parkinson Disease
Xiangya Hospital of Central South University 1,000
Not applicableEnded earlyNCT04919356
What this trial is testing

Parkinson's Disease G2019S LRRK2 Genetic Testing Program

Who this might be right for
Parkinson's Disease
Escape Bio, Inc. 836
Testing effectiveness (Phase 2)Active Not RecruitingNCT06602193
What this trial is testing

Safety and Pharmacodynamic Effects of BIIB122 in Participants With LRRK2-Associated Parkinson's Disease (LRRK2-PD)

Who this might be right for
Parkinson Disease
Denali Therapeutics Inc. 50
Testing effectiveness (Phase 2)Looking for participantsNCT06680830
What this trial is testing

Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

Who this might be right for
Parkinson DiseaseParkinsonIdiopathic Parkinson Disease+2 more
Neuron23 Inc. 150
Post-approval studies (Phase 4)UnknownNCT05355064
What this trial is testing

Efficacy of Oral Administration of Trehalose in Patients With Parkinson Disease

Who this might be right for
Parkinson Disease
Neuromed IRCCS 20
Not applicableLooking for participantsNCT07642908
What this trial is testing

Striatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation

Who this might be right for
Parkinson Disease
University of Michigan 15
Not applicableStudy completedNCT01860118
What this trial is testing

LRRK2 and Other Novel Exosome Proteins in Parkinson's Disease

Who this might be right for
Parkinson's Disease
University of Alabama at Birmingham 601
Not applicableEnded earlyNCT01618383
What this trial is testing

Study of the Enteric Nervous System Using Colonic Biopsies in Parkinson Patients With LRRK2 Mutation

Who this might be right for
Parkinson's Disease
Nantes University Hospital 19
Not applicableStudy completedNCT01536821
What this trial is testing

PROGENI (Parkinson's Research: The Organized Genetics Initiative) Family Study of LRRK2 (Leucine-rich Repeat Kinase 2)

Who this might be right for
Parkinson Disease
Indiana University 81
Not applicableUnknownNCT01089283
What this trial is testing

Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients With Different Genetic Characteristics

Who this might be right for
Parkinson Disease
Tel-Aviv Sourasky Medical Center 80
Not applicableEnded earlyNCT00467090
What this trial is testing

Characteristics of Parkinson s Disease Associated With the LRRK-2 Gene Mutation

Who this might be right for
Parkinson Disease
National Institute of Neurological Disorders and Stroke (NINDS) 34
Not applicableUnknownNCT04387812
What this trial is testing

Evaluation of the Frequency and Severity of Sleep Abnormalities in Patients With Parkinson's Disease

Who this might be right for
Parkinson DiseaseGBA Gene MutationLeucine-rich Repeat Kinase 2 (LRRK2) Gene Mutation
Tel-Aviv Sourasky Medical Center 240